The COMPASSION Study

Clinical trial NCT06507930 · RECRUITING

Trial details

NCT number: NCT06507930
Sponsor: Dana-Farber Cancer Institute
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Breast Cancer Metastatic Breast Cancer Advanced Breast Cancer Unresectable Breast Carcinoma

Start date: 2024-09-01
Primary completion: 2026-10-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.